1,240
Participants
Start Date
April 30, 2008
Primary Completion Date
September 30, 2010
Study Completion Date
August 31, 2011
Ranibizumab
Participants received a 0.5 mg dose of Ranibizumab via intravitreal (IVT) injection administered every 4 weeks for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
Participants received a 2.0 mg dose of Aflibercept Injection administered every 4 weeks for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
Participants received a 0.5 mg dose of Aflibercept Injection administered every 4 weeks for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
Participants received a 2.0 mg dose of Aflibercept Injection administered every 8 weeks (including one additional 2,0 mg dose at Week 4) for the first year. Thereafter a dose may be administered as frequently as every 4 weeks, but no less frequently than every 12 weeks.
Riga
Riga
Riga
Budapest
Vienna
Budapest
Budapest
Geneva
Sydney
Chatswood
Westmead
Parramatta
Leiden
East Melbourne
Bern
Parkville
Liège
Linz
Basel
Nedlands
Innsbruck
Zurich
Veszprém
Prague
Torino
Stockholm
Berlin
Marseille
Prague
Santiago de Compostela
Genova
Milan
Milan
Milan
Hamburg
Dijon
Varese
Lübeck
Kiel
Besançon
Madrid
Madrid
Málaga
Pamplona
Chihuahua City
Bordeaux
Oviedo
Udine
Haifa
Padua
Verona
Seville
Seville
Nantes
Zapopan
Essen
Valencia
Valencia
Valladolid
Münster
Petah Tikva
Cologne
Aachen
Metepec
Bonn
Mainz
Linköping
Ancona
Brno
Monterrey
Tel Aviv
Darmstadt
Monterrey
Homburg
Ludwigshafen am Rhein
Lyon
Lyon
Heidelberg
Bari
Örebro
Zrifin
Tübingen
Paris
Paris
Paris
Rehovot
Olomouc
Freiburg im Breisgau
Bratislava
München
Jerusalem
Regensburg
Catania
Banská Bystrica
New Delhi
New Delhi
Singapore
Singapore
Chandigarh
Singapore
Singapore
Ahemedabad - 4
Wadala, Mumbai
Bangalore
Pondicherry
Coimbatore
Kerala
Kolkata
Buenos Aires
Buenos Aires
Buenos Aires
Buenos Aires
Córdoba
Rosario
Ribeirão Preto
São Paulo
São Paulo
Minas Gerais
Medellín
Bogotá
Cali
Kfar Saba
Afula
Beersheba
Tel Litwinsky
Ústí nad Labem
Dresden
Dresden
Leipzig
Chennai
Madurai
Hyderabad
Mumbai
Orissa
Roma
Roma
Roma
Nagoya
Nagoya
Urayasu
Fukuoka
Fukushima
Maebashi
Sapporo
Kita
Kagoshima
Kyoto
Hirakata
Suita
Ōtsu
Chiyoda-ku
Shinjuku-ku
Mexico City
Mexico City
México D.F.
Amsterdam
Groningen
Nijmegen
Rotterdam
Bydgoszcz
Gdansk
Katowice
Poznan
Warsaw
Warszaa
Wroclaw
Coimbra
Porto
Seongnam
Incheon
Seoul
Seoul
Seoul
Seoul
Alicante
Barcelona
Barcelona
Barcelona
Barcelona
Southampton
Camberley
Aberdeen
Belfast
Birmingham
Liverpool
London
London
Plymouth
Torquay
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Bayer
INDUSTRY